FISONS SEES STRONG INTERNATIONAL GROWTH IN LONDON March Fisons Plc FISN L said strong international growth had been the main feature of the group s progress with the pharmaceutical division reporting a pct increase in U S Sales during the period The rise was due to a sustained marketing programme a larger sales force and the introduction of an aerosol form of its Intal anti asthma drug which pushed U S Sales up pct The company was commenting on results which saw pre tax profits rising to mln stg from mln in The result was in line with market forecasts but its shares nevertheless eased in a falling market to p at GMT from p Fisons said the potential for future growth of Intral as well as its Opticrom and Nasalcrom products was clearly indicated by a strong performance The scientific equipment business had raised the proportion of high technology products it manufactures and also raised its ability to generate higher margins The horticulture operations had demonstrated outstanding marketing ability Underlying cash flow from all three operations had been positive despite a full programme of capital investment Action to protect the group against foreign currency movements resulted in a small net gain to profits REUTER